Literature DB >> 1986144

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes.

S J Rubin1, D E Hallahan, C R Ashman, D G Brachman, M A Beckett, S Virudachalam, D W Yandell, R R Weichselbaum.   

Abstract

Two prostate carcinoma cell lines, DU-145 and PC-3, were examined for abnormalities in the retinoblastoma (Rb) and the p53 putative tumor suppressor genes. We found an abnormal Rb gene product in DU-145 using Western blot analysis. Polymerase chain reaction amplification followed by direct DNA sequencing demonstrated a base substitution mutation that generates a stop codon in exon 21. On Northern, Southern, and Western blot analysis, the p53 gene and its product appear to be normal in DU-145. PC-3, however, failed to demonstrate expression of either the p53 transcript on Northern blot analysis or the p53 protein on Western blot analysis, while the Rb gene products appeared to be normal on both Northern and Western blot analysis. This work extends the correlation between abnormal expression of putative tumor suppressor genes and human malignancies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986144     DOI: 10.1002/jso.2930460108

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  22 in total

1.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 2.  Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.

Authors:  Rong Hu; Constance Lay-Lay Saw; Rong Yu; Ah-Ng Tony Kong
Journal:  Antioxid Redox Signal       Date:  2010-08-17       Impact factor: 8.401

3.  Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.

Authors:  Juan Camilo Barreto-Andrade; Elena V Efimova; Helena J Mauceri; Michael A Beckett; Harold G Sutton; Thomas E Darga; Everett E Vokes; Mitchell C Posner; Stephen J Kron; Ralph R Weichselbaum
Journal:  Mol Cancer Ther       Date:  2011-05-13       Impact factor: 6.261

4.  Modeling a lethal prostate cancer variant with small-cell carcinoma features.

Authors:  Vassiliki Tzelepi; Jiexin Zhang; Jing-Fang Lu; Brittany Kleb; Guanglin Wu; Xinhai Wan; Anh Hoang; Eleni Efstathiou; Kanishka Sircar; Nora M Navone; Patricia Troncoso; Shoudan Liang; Christopher J Logothetis; Sankar N Maity; Ana M Aparicio
Journal:  Clin Cancer Res       Date:  2011-12-12       Impact factor: 12.531

5.  C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription.

Authors:  B A Slomiany; K L D'Arigo; M M Kelly; D T Kurtz
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Synergistic antimicrotubule therapy for prostate cancer.

Authors:  Vaishali Pannu; Prasanthi Karna; Hari Krishna Sajja; Deep Shukla; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2010-11-16       Impact factor: 5.858

7.  Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts.

Authors:  Alexandru V Korotcov; Yunpeng Ye; Yue Chen; Fayun Zhang; Sophia Huang; Stephen Lin; Rajagopalan Sridhar; Samuel Achilefu; Paul C Wang
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

8.  Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.

Authors:  Hsueh-Li Tan; Akshay Sood; Hameed A Rahimi; Wenle Wang; Nilesh Gupta; Jessica Hicks; Stacy Mosier; Christopher D Gocke; Jonathan I Epstein; George J Netto; Wennuan Liu; William B Isaacs; Angelo M De Marzo; Tamara L Lotan
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

9.  Prostate cancer in a transgenic mouse.

Authors:  N M Greenberg; F DeMayo; M J Finegold; D Medina; W D Tilley; J O Aspinall; G R Cunha; A A Donjacour; R J Matusik; J M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells.

Authors:  Benjamin M Johnson; Faisal F Y Radwan; Azim Hossain; Bently P Doonan; Jessica D Hathaway-Schrader; Jason M God; Christina V Voelkel-Johnson; Narendra L Banik; Sakamuri V Reddy; Azizul Haque
Journal:  J Cell Biochem       Date:  2018-10-30       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.